Before new medicines are allowed on the market, they have to pass a series of trials to ensure they’re safe. It’s a lengthy and expensive – but necessary – process for pharmaceutical companies. Out of...
Swiss pharmaceutical Roche is set to publish clinical study results, after being accused of covering negative outcomes. DW spoke with Michael Doherty, Global Head of Regulatory Affairs at Roche. DW: Roche has decided to open...